Amedisys, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Richard M. Ashworth
- Full Time Employees
- 19,000
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Address
- 3854 American Way Baton Rouge LA United States of America 70816
- IPO Date
- Aug 17, 1994
- CIK
- 0000896262
- Website
- amedisys.com
- Similar Companies
- Business
- Amedisys, Inc. (AMED) operates as a leading provider of home-based healthcare services in the United States, delivering home health, hospice, palliative, and high-acuity care to patients nationwide. Founded in 1982 and headquartered in Baton Rouge, Louisiana, with an additional executive office in Nashville, Tennessee, the company offers skilled nursing; physical, occupational, and speech therapy; medical social work; home health aides; personal care services including companion care, homemaker services, and live-in care; hospice care encompassing pain and symptom management, emotional and spiritual support, and bereavement counseling; palliative care for symptom relief and quality-of-life enhancement; and high-acuity care through its Contessa Health division featuring IV therapy, wound care, remote patient monitoring, and telehealth for hospital-level needs at home. Amedisys serves patients recovering from illness or surgery, those with chronic conditions, and individuals with life-limiting illnesses, primarily through Medicare reimbursement, across a network of care centers that supports over 499,000 patients annually with approximately 19,000 employees. As of August 14, 2025, Amedisys functions as a subsidiary of Optum, Inc., following Optum's $3.3 billion acquisition completed after regulatory settlement requiring divestiture of 164 locations; certain divested home health and hospice assets, generating $187 million in revenue from 54 locations, were acquired by Pennant Group in late 2025, while others went to BrightSpring, marking a major restructuring to facilitate the UnitedHealth Group integration.
Company News
Joel Greenblatt's Strategic Moves: A Closer Look at SPDR S&P 500 ETF Trust
Twilio Set to Join S&P MidCap 400
Amedisys: Thoughts On UnitedHealth Merger, Plus Underlying Factors
Amedisys (AMED) is a Top-Ranked Value Stock: Should You Buy?
Amedisys (AMED) Q2 Revenue Tops 5%
Here's What Key Metrics Tell Us About Amedisys (AMED) Q2 Earnings
Amedisys (AMED) Beats Q2 Earnings and Revenue Estimates
Amedisys Reports Second Quarter 2025 Financial Results
Here's Why You Should Retain AMED Stock in Your Portfolio for Now
AMED or CHE: Which Is the Better Value Stock Right Now?
Are Medical Stocks Lagging Amedisys (AMED) This Year?
AMED Stock Trades Flat Despite Q1 Earnings Beat, Margins Rise
Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics
Amedisys (AMED) Tops Q1 Earnings Estimates
Amedisys Reports First Quarter 2025 Financial Results
Amedisys (AMED) Earnings Expected to Grow: Should You Buy?
Why Is Amedisys (AMED) Up 1.3% Since Last Earnings Report?
Here's Why You Should Retain AMED Stock in Your Portfolio Now
AMED Q4 Earnings and Revenues Miss, Margins Dip, Stock Rises
Amedisys (AMED) Reports Q4 Earnings: What Key Metrics Have to Say